During 1944–1950, antimicrobial pharmacodynamics began to frame dosing around pharmacokinetic principles, prioritizing blood-level targets and minimal effective dosing, with schedules guided by early penicillin pharmacology and animal dynamics. There was rising attention to tissue distribution and site-specific efficacy, including penetration into ocular aqueous humor and broader distribution and excretion patterns that shaped therapeutic exposure at infection sites. The antibiotic repertoire expanded to aureomycin and chloromycetin, with in vitro activity and early therapeutic reports across diverse infections. Clinical translations of disease-targeted penicillin therapies showed early successes in pneumococcic meningitis and streptococcal pharyngitis/tonsillitis, illustrating rapid bench-to-bedside impact.